Department of Obstetrics and Gynecology, Istanbul University, Istanbul Faculty of Medicine, Capa, 34093, Istanbul, Turkey.
Department of Midwifery, University of Health Sciences, Hamidiye Faculty of Health Sciences, Istanbul, Turkey.
Int Urogynecol J. 2021 May;32(5):1265-1271. doi: 10.1007/s00192-020-04667-w. Epub 2021 Feb 19.
Female sexual function is influenced by the emotional and hormonal state. COVID-19 has been the major global health crisis of our time with high psychosocial impact. Vaginismus is a form of female sexual dysfunction and a subset of genitopelvic pain/penetration disorder in which any form of vaginal penetration is painful or impossible. Our aim was to evaluate the effect of the COVID-19 pandemic on sexual function of women treated for vaginismus.
All women treated using dilators between 2018-2019 were included. Data obtained 3 months after comfortable penetration and during the pandemic via telephone interview were compared. The Female Sexual Function Index (FSFI), Golombok-Rust Inventory of Sexual Satisfaction (GRISS), and Beck Depression Inventory (BDI) were used to evaluate sexual function and depression. Frequency of sexual intercourse and pain was compared using a visual analogue scale.
Seventy-seven women were included. Mean duration of treatment and number of treatment sessions were 3.5 ± 2.6 months and 4.2 ± 2.6, respectively. There were significant improvements in the FSFI desire, arousal, orgasm, and pain subscales and total score and in the GRISS infrequency, noncommunication, avoidance, non-sensuality, and vaginismus subscales and total score during the pandemic. The GRISS dissatisfaction and anorgasmia subscales and BDI score significantly worsened. Mean frequency of sexual intercourse was 2.3 ± 1.8/week and did not change significantly. Pain scores decreased during the pandemic (2.7 ± 2.8) compared to post-treatment (6.2 ± 2.9).
Although frequency of sexual intercourse was not affected and pain scores and FSFI total and subscale scores improved, satisfaction and orgasm were adversely affected, which may be attributed to increased stress and anxiety during the pandemic.
女性性功能受到情绪和激素状态的影响。COVID-19 是我们这个时代的主要全球健康危机，对心理健康有重大影响。阴道痉挛是女性性功能障碍的一种形式，也是女性生殖器疼痛/插入障碍的一个子集，任何形式的阴道插入都会引起疼痛或无法进行。我们的目的是评估 COVID-19 大流行对阴道痉挛治疗女性的性功能的影响。
所有 2018-2019 年期间使用扩张器治疗的女性均被纳入研究。通过电话访谈在舒适插入后 3 个月和大流行期间获得数据，并进行比较。采用女性性功能指数（FSFI）、Golombok-Rust 性满意度量表（GRISS）和贝克抑郁量表（BDI）评估性功能和抑郁情况。采用视觉模拟量表比较性交频率和疼痛程度。
共纳入 77 名女性。平均治疗时间和治疗次数分别为 3.5 ± 2.6 个月和 4.2 ± 2.6。在大流行期间，FSFI 的欲望、唤起、性高潮和疼痛子量表以及总分，以及 GRISS 的不频繁、非沟通、回避、非性感和阴道痉挛子量表以及总分均有显著改善。GRISS 的不满和性高潮障碍子量表和 BDI 评分显著恶化。平均性交频率为 2.3 ± 1.8/周，无显著变化。与治疗后相比（6.2 ± 2.9），疼痛评分在大流行期间下降（2.7 ± 2.8）。
尽管性交频率未受影响，疼痛评分以及 FSFI 总分和子量表评分有所改善，但满意度和性高潮受到不利影响，这可能归因于大流行期间的压力和焦虑增加。
